MWNA
YARW

Marshall Wace North America’s Yarrow Bioscience YARW Stock Holding History

Marshall Wace North America’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-203
Closed -$1.25M – 1814
2021
Q1 		$1.25M Buy
+203
New +$1.47M 0.01% 967
2019
Q1 		– Sell
-5
Closed -$80K – 1931
2018
Q4 		$80K Buy
+5
New +$112K ﹤0.01% 1131
2018
Q2 		– Sell
-9
Closed -$1.18M – 1717
2018
Q1 		$1.18M Buy
+9
New +$1.09M 0.01% 949

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Marshall Wace North America's YARW Position: Q2 2021 in Review

Marshall Wace North America sold out of Yarrow Bioscience (YARW) in Q2 2021, closing a stake of 203 shares — an estimated $1.25M sold.

Marshall Wace North America first reported a position in YARW in Q1 2018 and held it in 3 quarters. The position peaked at $1.25M in Q1 2021. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

  • Marshall Wace North America reported no remaining Yarrow Bioscience position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 203 Yarrow Bioscience shares in Q2 2021, an estimated $1.25M.
  • Marshall Wace North America first reported a position in Yarrow Bioscience in Q1 2018 and held it in 3 quarters.
  • Marshall Wace North America's Yarrow Bioscience position peaked at $1.25M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.